GLP-1 RA treatment is associated with cancer risk reduction including colorectal, gallbladder, esophageal, liver, kidney, pancreatic and ovarian cancers; beneficial effects for meningioma and multiple myeloma are also noted. Here, GLP1R is linked to ovarian carcinoma.